Sofosbuvir Based Regimens in the Treatment of Chronic Hepatitis C with Compensated Liver Cirrhosis in Community Care Setting

BACKGROUND: Direct-acting antiviral (DAA) drugs have been highly effective in the treatment of chronic hepatitis C (CHC) infection. We aim to evaluate the treatment response of Sofosbuvir based DAA in CHC patients with compensated liver cirrhosis as limited data exists in the real-world community se...

Descripción completa

Detalles Bibliográficos
Autores principales: Gayam, Vijay, Mandal, Amrendra Kumar, Khalid, Mazin, Mukhtar, Osama, Gill, Arshpal, Garlapati, Pavani, Khalid, Mowyad, Mansour, Mohammed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093047/
https://www.ncbi.nlm.nih.gov/pubmed/30155312
http://dx.doi.org/10.1155/2018/4136253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093047/
https://www.ncbi.nlm.nih.gov/pubmed/30155312
http://dx.doi.org/10.1155/2018/4136253

Ejemplares similares